Why Engage?
Jay Seemann
Vice President, Market Access
BeOne Medicines
Our perspective on pricing & value
At BeOne Medicines, formerly known as BeiGene, we are determined to take an innovative approach to drug pricing. Our goal is to bring improved and novel therapies to the greatest number of patients in ways that are fair, conscientious, and responsible.
We believe in:
- Striving to lower the total cost of care
- Pricing our products to provide maximum value vs in-class competitors
- Lowering out-of-pocket costs for patients
Our value story begins with the clinical utility of our products. This value is created in the lab, substantiated in pivotal trials, and validated in the real world. It’s supported both by credible health economics data and by BeOne’s continued commitment to innovation in oncology.
Investment in clinical trials
BeOne invests in robust clinical trials, including head-to-head studies aimed at establishing treatment superiority, to provide access decision makers with the clinical evidence they need to make informed decisions.
We continue to expand our clinical trial footprint to advance products across multiple disease states (eg, oncology, hematology, inflammation, and immunology) and indications.
Our vision & values
Our vision
- Leading through innovation
- Building strong, successful partnerships
- Differentiating BeOne by making a meaningful difference in patients’ lives and the healthcare system
Our core values
Ensure appropriate utilization of BeOne therapies and facilitate access for appropriate patients across care settings
Drive awareness of unmet needs and generate clinical and economic evidence that differentiates and highlights the value proposition for BeOne therapies
Work with customers to identify areas for collaboration and partnership that benefit patients and the healthcare system
BeOne Medicines resources
Mental health resources to drive change
BeOne is proud to sponsor Talk About It, a unique website that provides helpful patient- and HCP-focused tools and resources to empower those impacted by cancer to address mental health issues and engage in important dialogues to drive change.
Please encourage your members and providers to visit the site and explore the videos, fact sheets, and other resources available through this valuable program.
Investigational product portfolio
We are pursuing a broad and deep pipeline with the potential to address the vast majority of the world’s cancers. In addition to leveraging our internal research resources, we continually evaluate external preclinical and early-stage assets that might expand our pipeline and contribute to our durable competitive advantages.
Contact Us
Learn about our approved products
Learn about our Patient Assistance Program
To report an adverse event or side effect, please contact us at adverse_events@beigene.com
Stay up-to-date on the latest news and developments at BeOne